Viewing Study NCT05345158


Ignite Creation Date: 2025-12-25 @ 12:13 AM
Ignite Modification Date: 2026-01-01 @ 12:19 AM
Study NCT ID: NCT05345158
Status: RECRUITING
Last Update Posted: 2025-12-19
First Post: 2022-03-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: R-RPLND as First-line Treatment for Clinical Stage IIA/B Testicular Seminoma
Sponsor: University Health Network, Toronto
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module